1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Molecular Diagnostics for Infectious Disease Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Molecular Diagnostics for Infectious Disease Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Molecular Diagnostics for Infectious Disease Market Regional Analysis
6.2 Asia Pacific Molecular Diagnostics for Infectious Disease Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Molecular Diagnostics for Infectious Disease Market Forecast Analysis
7. Asia Pacific Molecular Diagnostics for Infectious Disease Market Analysis – by Type
7.1 Point-of-Care Testing and Laboratory Testing
- 7.1.1 Overview
- 7.1.2 Point-of-Care Testing and Laboratory Testing: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Asia Pacific Molecular Diagnostics for Infectious Disease Market Analysis – by End User
8.1 Human Testing and Vet Testing
- 8.1.1 Overview
- 8.1.2 Human Testing and Vet Testing: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Asia Pacific Molecular Diagnostics for Infectious Disease Market Analysis – by Application
9.1 Detection of Single Pathogen
- 9.1.1 Overview
- 9.1.2 Detection of Single Pathogen: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Detection of Two or More Pathogens
- 9.2.1 Overview
- 9.2.2 Detection of Two or More Pathogens: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Evaluation of Emerging Novel Infections
- 9.3.1 Overview
- 9.3.2 Evaluation of Emerging Novel Infections: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker
- 9.4.1 Overview
- 9.4.2 Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Antimicrobial Resistance Profiling
- 9.5.1 Overview
- 9.5.2 Antimicrobial Resistance Profiling: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Patient stratification
- 9.6.1 Overview
- 9.6.2 Patient stratification: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.7 Drug Regimen Selection
- 9.7.1 Overview
- 9.7.2 Drug Regimen Selection: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.8 Toxicity Avoidance
- 9.8.1 Overview
- 9.8.2 Toxicity Avoidance: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.9 Therapeutic Monitoring
- 9.9.1 Overview
- 9.9.2 Therapeutic Monitoring: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.10 Detection of Predisposition to Disease
- 9.10.1 Overview
- 9.10.2 Detection of Predisposition to Disease: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Asia Pacific Molecular Diagnostics for Infectious Disease Market Analysis – by Disease Type
10.1 Sepsis
- 10.1.1 Overview
- 10.1.2 Sepsis: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Prosthetic Joint Infection
- 10.2.1 Overview
- 10.2.2 Prosthetic Joint Infection: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Endocarditis
- 10.3.1 Overview
- 10.3.2 Endocarditis: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.4 STDs
- 10.4.1 Overview
- 10.4.2 STDs: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.5 Mononucleosis
- 10.5.1 Overview
- 10.5.2 Mononucleosis: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.6 Group A Streptococcus
- 10.6.1 Overview
- 10.6.2 Group A Streptococcus: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.7 Sepsis
- 10.7.1 Overview
- 10.7.2 Sepsis: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.8 Prosthetic Joint Infection
- 10.8.1 Overview
- 10.8.2 Prosthetic Joint Infection: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.9 Endocarditis
- 10.9.1 Overview
- 10.9.2 Endocarditis: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.10 STDs
- 10.10.1 Overview
- 10.10.2 STDs: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.11 Chlamydia
- 10.11.1 Overview
- 10.11.2 Chlamydia: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.12 Gastrointestinal Infection
- 10.12.1 Overview
- 10.12.2 Gastrointestinal Infection: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.13 Tuberculosis
- 10.13.1 Overview
- 10.13.2 Tuberculosis: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.14 H1N1 Virus
- 10.14.1 Overview
- 10.14.2 H1N1 Virus: Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Asia Pacific Molecular Diagnostics for Infectious Disease Market – Asia-Pacific Analysis
11.1 Overview
11.2 Asia-Pacific
- 11.2.1 Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 China:
Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 China: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.1.2 China: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.1.3 China: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.1.4 China: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.2 India:
Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 India: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.2.2 India: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.2.3 India: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.2.4 India: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.3 Japan:
Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Japan: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.3.2 Japan: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.3.3 Japan: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.3.4 Japan: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.4 Australia:
Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Australia: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.4.2 Australia: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.4.3 Australia: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.4.4 Australia: Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.5 Rest of Asia-Pacific :
Asia Pacific Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 bioMerieux SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Bruker Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Danaher Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 DiaSorin SpA
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 F. Hoffmann-La Roche Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Hologic Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Siemens Healthineers AG
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Thermo Fisher Scientific Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Asia Pacific Molecular Diagnostics for Infectious Disease Market
